Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2019 Jun;127(2):117-121.
doi: 10.1016/j.ymgme.2019.04.002. Epub 2019 Apr 12.

Clinical and biochemical footprints of inherited metabolic diseases. II. Metabolic liver diseases

Affiliations
Review

Clinical and biochemical footprints of inherited metabolic diseases. II. Metabolic liver diseases

Carlos R Ferreira et al. Mol Genet Metab. 2019 Jun.

Abstract

Inherited metabolic diseases account for about one third of pediatric patients with hepatomegaly, acute liver failure, cirrhosis or cholestasis. Specifically for pediatric acute liver failure, they account for 10-15% of cases, with a mortality of 22-65%. The percentage of acute liver failure caused by an inherited metabolic disease in children <2-3 years of age is even higher, ranging from a third to half of all cases. Metabolic liver disease accounts for 8-13% of all pediatric liver transplantations. Despite this high burden of disease, underdiagnosis remains common. We reviewed and updated the list of known metabolic etiologies associated with various types of metabolic liver involvement, and found 142 relevant inborn errors of metabolism. This represents the second of a series of articles attempting to create and maintain a comprehensive list of clinical and metabolic differential diagnoses according to system involvement.

Keywords: Acute liver failure; Cholestasis; Cirrhosis; Elevated liver enzymes; Fatty liver; Hepatic adenomas; Hepatocellular carcinoma; Hepatomegaly; Inborn errors of metabolism; Inherited metabolic diseases; Metabolic liver disease; Steatosis.

PubMed Disclaimer

Conflict of interest statement

Declarations of interest: none

Similar articles

Cited by

References

    1. Lee JJY, Wasserman WW, Hoffmann GF, van Karnebeek CDM, Blau N, Knowledge base and mini-expert platform for the diagnosis of inborn errors of metabolism, Genet. Med. Off. J. Am. Coll. Med. Genet 20 (2018) 151–158. - PMC - PubMed
    1. Ferreira CR, van Karnebeek CDM, Vockley J, Blau N, A proposed nosology of inborn errors of metabolism, Genet. Med. Off. J. Am. Coll. Med. Genet (2018). - PMC - PubMed
    1. McKiernan P, Ball S, Santra S, Foster K, Fratter C, Poulton J, Craig K, McFarland R, Rahman S, Hargreaves I, Gupte G, Sharif K, Taylor RW, Incidence of Primary Mitochondrial Disease in Children Younger Than 2 Years Presenting With Acute Liver Failure, J. Pediatr. Gastroenterol. Nutr 63 (2016) 592–597. doi:10.1097/MPG.0000000000001345. - DOI - PMC - PubMed
    1. Al-Hussaini A, Faqeih E, El-Hattab AW, Alfadhel M, Asery A, Alsaleem B, Bakhsh E, Ali A, Alasmari A, Lone K, Nahari A, Eyaid W, Al Balwi M, Craig K, Butterworth A, He L, Taylor RW, Clinical and molecular characteristics of mitochondrial DNA depletion syndrome associated with neonatal cholestasis and liver failure, J. Pediatr 164 (2014) 553–559.e1–2. doi:10.1016/j.jpeds.2013.10.082. - DOI - PubMed
    1. Venick RS, Farmer DG, Soto JR, Vargas J, Yersiz H, Kaldas FM, Agopian VG, Hiatt JR, McDiarmid SV, Busuttil RW, One Thousand Pediatric Liver Transplants During Thirty Years: Lessons Learned, J. Am. Coll. Surg 226 (2018) 355–366. doi:10.1016/j.jamcollsurg.2017.12.042. - DOI - PubMed

MeSH terms